A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats

PURPOSE: Enobosarm (EN), a selective androgen receptor modulator and raloxifene (RAL), a selective estrogen receptor modulator, have been shown to improve bone tissue in osteoporotic males. The present study evaluated the effects of a combination therapy of EN and RAL on bone properties in orchiecto...

Descripción completa

Detalles Bibliográficos
Autores principales: Komrakova, M., Büchler, G., Böker, K. O., Lehmann, W., Schilling, A. F., Roch, P. J., Taudien, S., Hoffmann, D. B., Sehmisch, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646546/
https://www.ncbi.nlm.nih.gov/pubmed/35867330
http://dx.doi.org/10.1007/s40618-022-01865-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646546/
https://www.ncbi.nlm.nih.gov/pubmed/35867330
http://dx.doi.org/10.1007/s40618-022-01865-9

Ejemplares similares